EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Self-ControlFood Cravings
Interventions
DEVICE

ActiveTreatment with BTL-699-2

Participants will receive six transcranial magnetic stimulation treatments with the BTL-699-2 device over the left dorsolateral prefrontal cortex. The intensity will be adjusted according to the subject's feedback, up to 70% of the individual's motor threshold. The treatments will be spaced 3 - 7 days apart.

DEVICE

Sham Treatment with BTL-699-2

Participants will receive six transcranial magnetic stimulation treatments with the BTL-699-2 device over the left dorsolateral prefrontal cortex. The intensity will se to 5% of the individual's motor threshold. The treatments will be spaced 3 - 7 days apart.

Trial Locations (4)

33156

A New You Wellness, Miami

43215

Jiva Med Spa, Columbus

47630

Cady Wellness Institute, Newburgh

80211

Aria Integrative Health, Denver

All Listed Sponsors
lead

BTL Industries Ltd.

INDUSTRY

NCT07056036 - EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings | Biotech Hunter | Biotech Hunter